Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
18 Apr 2024 21:41 CEST |
VEOLIA ENVIRONNEMENT | Veolia Sets Bold Growth Goals in the United States, Boosting Its Ecological Solutions to Improve Economic Growth and Public Health for Americans | 65102030 Water | Other subject |
18 Apr 2024 21:41 CEST |
VEOLIA ENVIRONNEMENT | Veolia fixe des objectifs de croissance ambitieux aux États-Unis en renforçant ses solutions écologiques au service de la croissance économique et de la santé publique des Américains | 65102030 Water | Other subject |
18 Apr 2024 20:46 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics Annual report 2023 | 20103010 Biotechnology | Annual financial and audit Reports |
18 Apr 2024 20:38 CEST |
AMUNDI | Mise à disposition du Document d’Enregistrement Universel 2023 | 30202010 Asset Managers and Custodians | Corporate life |
18 Apr 2024 20:38 CEST |
AMUNDI | 2023 Universal Registration Document available | 30202010 Asset Managers and Custodians | Corporate life |
18 Apr 2024 20:02 CEST |
MANITOU BF | Mise à disposition du Document d’Enregistrement Universel 2023 | 50204020 Machinery: Construction and Handling | Income |
18 Apr 2024 20:02 CEST |
MANITOU BF | Availability of the 2023 Universal Registration Document (URD) | 50204020 Machinery: Construction and Handling | Income |
18 Apr 2024 19:50 CEST |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
18 Apr 2024 19:29 CEST |
ECOSLOPS | Ecoslops : 2023 annual results | 60101030 Oil Equipment and Services | - |
18 Apr 2024 19:29 CEST |
ECOSLOPS | Ecoslops : Résultats annuels 2023 | 60101030 Oil Equipment and Services | - |
18 Apr 2024 19:03 CEST |
DANONE | DANONE : Informations relatives au nombre total de droits de vote et d’actions | 45102020 Food Products | Other subject |
18 Apr 2024 19:03 CEST |
DANONE | Danone: Information on the total number of voting rights and shares | 45102020 Food Products | Other subject |
18 Apr 2024 19:01 CEST |
POLIGHT | poLight ASA: Extraordinary general meeting held | 10102015 Electronic Components | Additional regulated information required to be disclosed under the laws of a Member State |
18 Apr 2024 19:00 CEST |
VIEL ET COMPAGNIE | VIEL & Cie : Réduction de capital par annulation d’actions | 30202015 Investment Services | Other financial transaction |
18 Apr 2024 19:00 CEST |
DEKUPLE | DÉKUPLE: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 | 40301020 Media Agencies | Income |
18 Apr 2024 18:50 CEST |
MARTINS-S.G.P.S. SA(JERONIMO) | Jerónimo Martins, SGPS, S.A. informa sobre Pagamento de Dividendos | 45201010 Food Retailers and Wholesalers | Dividend |
18 Apr 2024 18:50 CEST |
MARTINS-S.G.P.S. SA(JERONIMO) | Jerónimo Martins, SGPS, S.A. informs on Dividend Payment | 45201010 Food Retailers and Wholesalers | Dividend |
18 Apr 2024 18:49 CEST |
MARTINS-S.G.P.S. SA(JERONIMO) | Jerónimo Martins, SGPS, S.A. informa sobre Relatório do Governo da Sociedade de 2023 aprovado na Assembleia Geral de Acionistas de 18 de abril de 2024 | 45201010 Food Retailers and Wholesalers | Other subject |
18 Apr 2024 18:48 CEST |
MARTINS-S.G.P.S. SA(JERONIMO) | Jerónimo Martins, SGPS, S.A. informs on 2023 Corporate Governance Report approved at the Annual General Shareholders Meeting of April 18, 2024 | 45201010 Food Retailers and Wholesalers | Other subject |
18 Apr 2024 18:40 CEST |
MARTINS-S.G.P.S. SA(JERONIMO) | Jerónimo Martins, SGPS, S.A, informa sobre Relatório e Contas Anual 2023 aprovado em Assembleia Geral de Acionistas de 18 de abril de 2024 – versão não conforme com ESEF | 45201010 Food Retailers and Wholesalers | Other subject |
18 Apr 2024 18:39 CEST |
MARTINS-S.G.P.S. SA(JERONIMO) | Jerónimo Martins, SGPS, S.A. informs on 2023 Annual Report approved on the Annual General Meeting of April 18, 2024 – non-ESEF compliant version | 45201010 Food Retailers and Wholesalers | Other subject |
18 Apr 2024 18:38 CEST |
MARTINS-S.G.P.S. SA(JERONIMO) | Jerónimo Martins, SGPS, S.A. informa sobre deliberações da Assembleia Geral de Acionistas de 2024 | 45201010 Food Retailers and Wholesalers | General meeting / Board Meeting |
18 Apr 2024 18:38 CEST |
MARTINS-S.G.P.S. SA(JERONIMO) | Jerónimo Martins, SGPS, S.A. informs on Resolutions of the AGM 2024 | 45201010 Food Retailers and Wholesalers | General meeting / Board Meeting |
18 Apr 2024 18:17 CEST |
SMTPC | SMTPC_Mise à disposition du Rapport annuel 2023 | 50206060 Transportation Services | Legal |
18 Apr 2024 18:15 CEST |
GROUPE SFPI | SFPI GROUP: publication of 2023 annual results | 40301030 Publishing | General meeting / Board Meeting |
18 Apr 2024 18:15 CEST |
GROUPE SFPI | SFPI GROUP: publication des résultats 2023 | 40301030 Publishing | General meeting / Board Meeting |
18 Apr 2024 18:11 CEST |
PHOTONIKE CAPITAL | Nucleus Life AG approval of Financial Statements 2023 next April, 29th. Net Profit at 596.897 CHF | 30202010 Asset Managers and Custodians | Commercial results |
18 Apr 2024 18:00 CEST |
L'OREAL | Chiffre d’affaires du 1er trimestre 2024 | 40204035 Cosmetics | Sales |
18 Apr 2024 18:00 CEST |
KERLINK | KERLINK : Résultats annuels 2023. Confiance dans les perspectives d’activité 2024. | 15101010 Telecommunications Equipment | General meeting / Board Meeting |
18 Apr 2024 18:00 CEST |
NEOLIFE | Changement de gouvernance à la tête du Conseil de surveillance de NEOLIFE | 50101035 Building Materials: Other | - |
18 Apr 2024 18:00 CEST |
PRODWAYS GROUP | Activité de 1er trimestre 2024 : 16 M EUR de revenus | 50204050 Machinery: Specialty | Sales, Income |
18 Apr 2024 18:00 CEST |
ONCODESIGN PRECISION MEDICINE | Degroof Petercam initie la couverture d’Oncodesign Precision Medicine | 20103010 Biotechnology | Other subject |
18 Apr 2024 18:00 CEST |
ESSILORLUXOTTICA | EssilorLuxottica: Chiffre d'affaires T1 2024 - Trajectoire solide du chiffre d’affaires au premier trimestre | 20102015 Medical Supplies | Commercial results |
18 Apr 2024 18:00 CEST |
AELIS FARMA | Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder | 20103010 Biotechnology | Other subject |
18 Apr 2024 18:00 CEST |
INTEGRAGEN | IntegraGen : Résultats annuels 2023 – Excédent brut d’exploitation positif reflétant la bonne maîtrise des coûts | 20103010 Biotechnology | Income |
18 Apr 2024 18:00 CEST |
INTEGRAGEN | IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control | 20103010 Biotechnology | Income |
18 Apr 2024 18:00 CEST |
AMPLITUDE SURGICAL | Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of €79.6m, up +6.1% at Constant Exchange Rates | 20102010 Medical Equipment | Sales |
18 Apr 2024 18:00 CEST |
THERANEXUS | Theranexus et BBDF annoncent les données finales et positives de sécurité et d'efficacité de Batten-1 dans l'étude de phase 1/2 | 20103010 Biotechnology | Legal |
18 Apr 2024 18:00 CEST |
L'OREAL | First quarter 2024 sales | 40204035 Cosmetics | Sales |
18 Apr 2024 18:00 CEST |
PRODWAYS GROUP | Activity of the 1st quarter 2024: EUR 16 M in revenue | 50204050 Machinery: Specialty | Sales, Income |
18 Apr 2024 18:00 CEST |
KERLINK | KERLINK : 2023 full-year results. Confident business outlook for 2024. | 15101010 Telecommunications Equipment | General meeting / Board Meeting |
18 Apr 2024 18:00 CEST |
ESSILORLUXOTTICA | EssilorLuxottica: Fatturato del primo trimestre 2024 - Solida traiettoria di crescita del fatturato nel primo trimestre | 20102015 Medical Supplies | Commercial results |
18 Apr 2024 18:00 CEST |
OBIZ S.A. | Le groupe Obiz(C) conclut un protocole d'accord en vue de l'acquisition de HA PLUS PME, plateforme d'achats qui permet aux entreprises de réaliser des économies | 10101020 Consumer Digital Services | Legal |
18 Apr 2024 18:00 CEST |
AMPLITUDE SURGICAL | Amplitude Surgical - Chiffre d’affaires consolidé 9 mois de l’exercice 2023-24 de 79,6 M€, en progression de +6,1% à taux constants | 20102010 Medical Equipment | Sales |
18 Apr 2024 18:00 CEST |
ESSILORLUXOTTICA | EssilorLuxottica: Q1 2024 Revenue - Solid revenue trend in the first quarter | 20102015 Medical Supplies | Commercial results |
18 Apr 2024 18:00 CEST |
AELIS FARMA | Aelis Farma annonce la dernière visite du dernier patient (Last Patient Last Visit ou LPLV) de l’étude de phase 2b avec AEF0117 dans le traitement de l’addiction au cannabis | 20103010 Biotechnology | Other subject |
18 Apr 2024 18:00 CEST |
ONCODESIGN PRECISION MEDICINE | Degroof Petercam Initiates Coverage of Oncodesign Precision Medicine | 20103010 Biotechnology | Other subject |
18 Apr 2024 18:00 CEST |
THERANEXUS | Theranexus and BBDF announce final and positive safety and efficacy data in the Phase I/II trial testing Batten-1 | 20103010 Biotechnology | Legal |
18 Apr 2024 17:55 CEST |
Genel Energy Finance 4 plc | Genel Energy Finance 4 plc – Reports and Accounts for the Year Ended 31 December 2023 | - | Annual financial and audit Reports |
18 Apr 2024 17:55 CEST |
Genel Energy Finance 4 plc | Genel Energy Finance 4 plc – Reports and Accounts for the Year Ended 31 December 2023 | - | Annual financial and audit Reports |